Abstract
Bladder augmentation (BA) with GI tissue is an important tool in the armamentarium of the urologist in the management of children requiring reconstruction for urinary incontinence, preserving the upper urinary tract, and reconstructions for severe congenital malformations. The main goal of bladder augmentation is a creation of a low-pressure urinary reservoir in order to maintain renal function and to avoid urinary incontinence. After introduction of clean intermitted catheterization to the clinical practice, augmentation cystoplasty (AC) with various intestinal segments grew rapidly and changed the management of pediatric and adult patients with abnormal bladder function. The current techniques for pediatric BA are cystoplasty with stomach, large bowel, small bowel, ileocecal, ureter, and engineered tissue with or without urinary continence procedures. Gastrointestinal tissue used for enterocystoplasty is associated with various short- and long-term complications, and the search for the ideal tissue is still ongoing (Adams et al. 1988; Hitchcock et al. 1994; Perovic et al. 2000). Reservoir perforation must be considered in patients with acute abdominal pain or peritonitis, and long-term follow-up of renal function is needed. The practicing urologists and pediatric surgeons have to be aware of the long-term risk of malignancy in these procedures. Therefore, there is a current necessity to develop alternative tissues for bladder augmentation by the help of tissue engineering protocols that will replace the integration of bowel segments into the urinary tract. Until then, intestinal cystoplasty still seems to be the gold standard due to the lack of promising alternative options.
References
Adams MC, Joseph DB. Urinary tract reconstruction in Children. In: Wein AJ, Kavoussi LR, et al., editors. Cambell’s urology. 10th ed. Philadelphia: WB Saunders; 2012. p. 3457–502.
Adams W, Shortliffe L. Management of delayed bladder augmentation perforation. Nat Clin Pract Urol. 2006;3:341–4.
Adams MC, Mitchell ME, Rink RC. Gastrocystoplasty: an alternative solution to the problem of urological reconstruction in the severely compromised patient. J Urol. 1988;140:1152–6.
Andolfi C, Kumar R, Boysen WR, Gundeti MS. Current status of robotic Surgery in pediatric urology. J Laparoendosc Adv Surg Tech A. 2019;29(2):159–66.
Arlen AM, Merriman LS, Elmore JM, Smith EA, Kirsch AJ. Rapid construction of sigmoid bladder augmentation using absorbable staples: long-term results and comparison to standard colocystoplasty in children with neurogenic bladder. J Pediatr Urol. 2014;10:284–8.
Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patient needing cystoplasty. Lancet. 2006;367:1241–6.
Austin JC. Long-term risks of bladder augmentation in pediatric patients. Curr Opin Urol. 2008;18:408–12.
Austin JC, Elliot S, Cooper CS. Patients with spina bifida and bladder cancer: atypical presentation, advanced stage, and poor survival. J Urol. 2007;178:798–801.
Barker G, Lackgren G, Stenberg A, Arnell K. Distal shunt obstruction in children with myelomeningocele after bladder perforation. J Urol. 2006;176:1726–8.
Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012;109:1280-93.12
Boylu U, Horasanli K, Tanriverdi O, Kendirci M, Gumus E, Miroglu C. Evaluation of bone mineral density after ileocystoplasty in children with and without myelomeningocele. Pediatr Surg Int. 2006;22(4):375–9.
Brkovic D, Linke J, Jakse G, Bauss F. Changes in bone structure after augmentation cystoplasty in chronic uraemic rats. BJU Int. 2005;95:1066–70.
Cartwright PC. Snow BW Bladder autoaugmentation: early clinical experience. J Urol. 1989a;142(2 Pt 2):505–8.
Cartwright PC. Snow BW Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol. 1989b;142(4):1050–3.
Castellan M, Gosalbez R, Perez-Brayfield M, et al. Tumor in bladder reservoir after gastrocystoplasty. J Urol. 2007;178:1771–4.
De Badiola F, Ruiz E, Puigdevall J, Lobos P, Moldes J, Lopez Raffo M, et al. Sigmoid cystoplasty with argon beam without mucosa. J Urol. 2001;165(6 Pt2):2253–5.
DeFoor W, Minevich E, Reeves D, et al. Gastrocystoplasty: long-term followup. J Urol. 2003a;170:1647–50.
DeFoor W, Tackett L, Minevich E, et al. Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology. 2003b;62:737–41.
DeFoor W, Minevich E, Reddy P, et al. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol. 2004;172:1964–6.
Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49:908–13.
Duckett JW, Snyder HMIII. Use of Mitrofanoff principle in urinary reconstruction. Urol Clin North Am. 1986;13:271–4.
Duel BP, Gonzalez R, Barthold JS. Alternative techniques for augmentation cystoplasty. J Urol. 1998;159:998–1005.
Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011;12
Elder JS, Snyder HM, Hulbert WC, et al. Perforation of the augmented bladder in patients undergoing clean intermittent catheterization. J Urol. 1988;140:1159–62.
Gold BD, Bhoopalam PS, Reifen RM, et al. Gastrointestinal complications of gastrocystoplasty. Arch Die Child. 1992;61:1272.
González R, Ludwikowski BM. Alternatives to conventional enterocystoplasty in children: a critical review of urodynamic outcomes. Front Pediatric. 2013;25:1–9.
Gonzalez R, Buson H, Reid C, Reinberg Y. Seromuscular colocystoplasty lined with urothelium: experience with 16 patients. Urology. 1995;45(1):124–9.
Gosalbez R Jr, Woodard JR, Bmecker BH, Parrott TS, Massad C. The use of stomach in pediatric urinary reconstruction. J Urol. 1993;150:438.
Gosalbez R, Woodard J, Broeker B, Warshaw B. Metabolic complications of the use of stomach for urinary reconstruction. J Urol. 1993;150:710–2.
Gundeti MS, Kojima Y, Haga N, Kiriluk K. Robotic-assisted laparoscopic reconstructive surgery in the lower urinary tract. Curr Urol Rep. 2013;14:333–41.
Gurocak S, Nuininga J, Ure I, De Gier RP, Tan MO, Feitz W. Bladder augmentation: review of the literature and recent advances. Indian J Urol. 2007a;23(4):452–7.
Gurocak S, de Gier RP, Feitz W. Bladder augmentation without the integration of intact bowel segments: critical review and future perspectives. J Urol. 2007b;177:839–44.
Hafez A, McLorie G, Gliday D, et al. Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol. 2003;170:1639–41.
Hensle TW, Bingham J, Lam J, Shabgish A. Preventing reservoir calculi after augmentation cystoplasty and continent urinary diversion: the influence of an irrigation protocol. BJU Int. 2004;93:585–7.
Higuchi TT, Granberg CF, Fox JA, Husmann DA. Augmentation cystoplasty and risk of neoplasia: fact, fiction and controversy. J Urol. 2010;184:2492–6.
Hitchcock RJ, Dufi PG, Malone PS. Ureterocystoplasty: the “bladder” augmentation of choice. Br J Urol. 1994;73:575.
Horst M, Eberli D, Gobet R, Salemi S. Tissue engineering in Pediatric bladder reconstruction-the road to success. Front Pediatr. 2019;29(7):91.
Husmann DA, Snodgrass WT, Koyle MA, Furness PD 3rd, Kropp BP, Cheng EY, Kaplan WE, Kramer SA. Ureterocystoplasty: indications for a successful augmentation. J Urol. 2004;171(1):376–80.
Johal NS, Hamid R, Aslam Z, Carr B, Cuckow PM, Duffy PG. Ureterocystoplasty: long-term functional results. J Urol. 2008;179:2373–5.
Kinahan TJ, Khoury AE, McLorie GA, Churchill BM. Omeprazole in postgastrocystoplasty metabolic alkalosis and aciduria. J Urol. 1992;147(2):435–7.
Kurzrock E, Baskin L, Kogan B. Gastrocystoplasty: is there a consensus? World J Urol. 1998a;16:242–50.
Kurzrock E, Baskin L, Kogan B. Gastrocystoplasty: long-term followup. J Urol. 1998b;160:2182–6.
Landau EH, Jayanthi VK, Khoury AE, et al. Bladder augmentation: ureterocystoplasty versus ileocystoplasty. J Urol. 1994;152:716.
Lendvay TS, Cowan CA, Mitchell MM, Joyner BD, Grady RW. Augmentation cystoplasty rates at children’s hospitals in the United States: a pediatric health information system database study. J Urol. 2006;176:1716–20.
Lima SV, Araújo LA, Vilar FO. Nonsecretory intestinocystoplasty: a 10-year experience. J Urol. 2004;171:2636–40.
MacNeily AE, Afshar K, Coleman GU, Johnson HW. Autoaugmentation by detrusor myotomy: its lack of effectiveness in the management of congenital neuropathic bladder. J Urol. 2003;170(4 Pt 2):1643–6. discussion 1646
Marte A, Di Meglio D, Cotrufo AM, Di Iorio G, De Pasquale M, Vessella A. A long-term follow-up of autoaugmentation in myelodysplastic children. BJU Int. 2002;89(9):928–31.
McDougal WS. Metabolic complications of urinary intestinal diversion. J Urol. 1992;147:1199–208.
Metcalfe P, Casale A, Kaefer M, et al. Spontaneous bladder perforations: a report of 500 augmentations in children and analysis of risk. J Urol. 2006;175:1466–71.
Mingin G, Nguyen H, Mathias R, et al. Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics. 2002;110:1193–8.
Mitrofanoff P. Cystostomie continente trans-appendiculaire dans le traitement des vessies neurologiques. Chir Pediatr. 1980;21:297–305.
Mittal S, Srinivasan A. Robotics in pediatric urology: evolution and the future. Urol Clin North Am. 2021;48(1):113–25.
Mundy AR, Noble JG. Bladder augmentation and substitution cystoplasty. In: Frank JD, Gearhart JP, Snyder III HM, editors. Operative pediatric urology. 2nd ed. London: Churchill Livingstone; 2002. p. 49–68.
Mundy AR, Stephenson TP. “Clam” ileocystoplasty for the treatment of refractory urge incontinence. Br J Urol. 1985;57:641–6.
N’Dow J, Robson CN, Matthews JN, et al. Reducing mucus production after urinary reconstruction: a prospective randomized trial. J Urol. 2001;165(5):1433–40.
Nahas WC, Lucon M, Mazzucchi E, Antonopoulos IM, Piovesan AC, Neto ED, Ianhez LE, Arap S. Clinical and urodynamic evaluation after ureterocystoplasty and kidney transplantation. J Urol. 2004;171(4):1428–31.
Nurse DE, Mundy AR. Metabolic complications after cystoplasty. Br J Urol. 1985;63:165–70.
Perovic SV, Vukadinovic VM, Djordjevic ML. Augmentation ureterocystoplasty could be performed more frequently. J Urol. 2000;164(3 Pt 2):924–7.
Plaire C, Snodgrass W, Grady R, Mitchell M. Long-term followup of the hematuria-dysuria syndrome. J Urol. 2000;164:921–3.
Radomski SB, Herschorn S, Stone AR. Urodynamic comparison of ileum vs. sigmoid in augmentation cystoplasty for neurogenic bladder dysfunction. Neurourol Urodyn. 1995;14:231–7.
Riccabona M, Koen M, Schindler M, Goedele B, Pycha A, Lusuardi L. Botulinum-a toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol. 2004;171:845–8.
Schlomer BJ, Copp HL. Cumulative incidence of outcomes and urologic procedures after augmentation cystoplasty. J Pediatric Urol 2014; in press.
Schlomer BJ, Saperston K, Baskin L. National trends in augmentation cystoplasties in the 2000s and factors associated with patient outcomes. J Urol. 2013;190(4):1352–7.
Shekarriz B, Upadhyay J, Demirbilek S, Barthold JS, Gonzαlez R. Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology. 2000;55:123–8.
Sheldon CA, Gilbert A, Wacksman J, Lewis AG. Gastrocystoplasty: technical and metabolic characteristics of the most versatile childhood bladder augmentation modality. J Ped Surg. 1995;30:283.
Smeulders N, Woodhouse C. Neoplasia in adult exstrophy patients. BJU Int. 2001;8:623–8.
Soergel TM, Cain MP, Misseri R, et al. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172:1649–52.
Sountoulides P, Laguna MP, de la Rosette JJ. Complications following augmentation cystoplasty; prevention and management. Central European Journal of Urology. 2009:216–21.
Szymanski KM, Misseri R, Whittam B, Lingeman JE, Amstutz S, Ring JD, Kaefer M, Rink RC, Cain MP. Bladder stones after bladder augmentation are not what they seem. J Pediatr Urol. 2016;12(2):98.e1–6.
Taskinen S, Fagerholm R, Makitie O. Skeletal health after intestinal bladder augmentation: findings in 54 patients. BJU Int. 2007;100:906–10.
Traxel E, DeFoor W, Minevich E, Reddy P, Alam S, Reeves D, Sheldon C. Low incidence of urinary tract infections following renal transplantation in children with bladder augmentation. J Urol. 2011;186(2):667–71.
Trevisani LFM, Nguyen HT. Current controversies in pediatric urologic robotic surgery. Curr Opin Urol. 2013;23:72–7.
Turner A, Subramanian R, Thomas DFM, et al. Transplantation of autologous differentiated urothelium in an experimental model of composite cystoplasty. Eur Urol. 2011;59:447–54.
Vates TS, Denes ED, Rabah R, Shapiro E, Suzer O, Freedman AL. González R Methods to enhance in vivo urothelial growth on seromuscular colonic segments in the dog. J Urol. 1997;158(3 Pt 2):1081–5.
Veeratterapillay R, Thorpe AC. Harding C Augmentation cystoplasty: Contemporary indications, techniques and complications. Indian J Urol. 2013;29(4):322–7.
Zhao F, Zhou L, Xu Z, Xu L, Xu Z, Ping W, Liu J, Zhou C, Wang M, Jia R. Hypoxia-preconditioned adipose-Derived endothelial progenitor cells promote bladder augmentation. Tissue Eng Part A. 2020;26(1–2):78–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Chertin, B., Koucherov, S., Shenfeld, O.Z. (2022). Augmentation Cystoplasty. In: Puri, P. (eds) Pediatric Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38482-0_196-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-38482-0_196-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38482-0
Online ISBN: 978-3-642-38482-0
eBook Packages: Springer Reference MedicineReference Module Medicine